Clinical Assessment of the Activity and the Tolerability of a Triticum Vulgare Extract-Containing Medical Device in Patients with Haemorrhoids

Giovanni Finucci¹ and Giorgio Saponati^2,

¹Endoscopy and Digestive Diseases Unit – Surgery Dpt.; S.Luca Hospital; Lucca, Italy

²ISPharm srl, Via dei Pubblici Macelli 194, Lucca, Italy

Cite this paper:
Giovanni Finucci and Giorgio Saponati. Clinical Assessment of the Activity and the Tolerability of a Triticum Vulgare Extract-Containing Medical Device in Patients with Haemorrhoids. Global Journal of Surgery. 2015; 3(1):8-11. doi: 10.12691/js-3-1-3

Abstract

Twenty outpatients suffering from symptomatic haemorrhoids were treated with a medical device in gel form containing watery extract of Triticum Vulgare, glycerine and Mucosave CG, given in three daily applications for 1-2 weeks. Signs and symptoms of haemorrhoids were evaluated at baseline (Visit 1) and after 1 (Visit 2) and 2 (Visit 3) weeks of treatment according to a 4-point rating scale (0 = absent, 1 = mild, 2 = moderate, 3 = intense). The primary variable of the study was the percentage of responder patients at Visit 2, defined as those patients in which the total Symptoms Score (TSS: sum of the scores of all symptoms) decreased at least 50% from the baseline value (V1). Two patients discontinued the treatment, one just before V2, inclusive of symptoms assessments, and another before V2 without evaluations. One patient did not attend V3. A decrease of at least 50% in TSS (i.e. a therapeutic success) was observed in 10 patients at week 1 and in 16 out of 17 patients at week 2. The mean TTS (mean baseline score: 8.47) decreased by 51% at week 1; a mean TTS score of 2 was observed at the end of study (p<0.05 vs baseline). Pain intensity and tenesmus were almost disappeared at the end of treatment. Improvements in burning and pruritus were evident just from week 1. Bleeding was present in almost all patients at baseline and greatly decreased from week 1. Mucorrhoea was present in 6 patients at baseline and disappeared during treatment. Interference with daily activities (mean baseline score: 1.8) significantly decreased at end of treatment (mean score: 0.4). No adverse events were recorded. The results of this study suggest that the device tested may represent an effective and safe method for the treatment of the haemorrhoids in symptomatic phase. (Study DAM/MD/001/12 approved by the Italian Ministry of Health).

Keywords:
haemorroids topical therapy triticum vulgare

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Chen H. Illustrative handbook of general surgery. Springer, Berlin, 2010; p. 217
[2]	Beck D. The ASCRS textbook of colon and rectal surgery, Springer, N.Y. 2011; pp 174-177.
[3]	Agbo SP. Surgical management of hemorrhoids. J Surg Tech 2011, 3 (2).
[4]	Kaidar-Person O. Hemorrhoidal disease. A comprehensive review. J Am Coll Surgeons, 2014 (1): 102-107, 2007.
[5]	Riss S, Weiser FA, Schwameis K et al. The prevalence of hemorrhoids in adults. Int J Colorectal Dis 2011.
[6]	Varut L. Hemorrhoids: from basic pathophysiology to clinical management. World J Gatroenterol 2102; 18 (17): 2009-2017.
[7]	Davies RJ. Haemorroids. Clinical Evidence, 15:711-24, 2006.
[8]	Audu O, Ara IB, Umar AA et al. Sociodemographic correlates of choice of health care services in six rural communities in north central Nigeria. Adv Pub Health 201.
[9]	Suares NC, Forda AC. Prevalence of, and risk factors for, cronic idiopathic constipation in the community: systematic review and meta-analysis . Am. J. Gastroenterol 2011; 106: 1582-1591.
[10]	Zielinski R, Searing K, Deibel M. Gastrointetsinal distress in pregnancy: prevalence, assessment and treatment of 5 common discomforts. J Perinat Neonatal Nurs 2015.
[11]	Sneider EB, Maikel JA. Diagnosis and management of symptomatic hemorroids. Surg Clin North Am 2010; 90:17-32
[12]	Misra MC. Drug treatment of haemorrhoids. Drugs, 65 (11): 1481-91, 2005
[13]	Martini P, Mazzatenta C, Saponati G. Efficacy and tolerability of Fitostimoline in two different forms (soaked gauzes and cream) and Citrizan gel in the topical treatment of second degree superficial cutaneous burns. Dermatology Res Pract, vol. 2011, article ID978291.
[14]	Boselli F, Petrella E, Campedelli A et al. Efficacy and tolerability of Fitostimoline (vaginal cream, ovules and vaginal washing) and of benzydamine hydrochloride (Tantum Rosa vaginal cream and vaginal washing) in the topical treatment of symptoms of bacterial vaginosis. ISRN Obstet Gynecol, vol. 2012 article 183406.
[15]	Serafini G, Saponati G. Attività e tollerabilità degli estratti di Triticum Vulgare nelle affezioni flogistico-distrofiche. Dental Clinics, 3: 35-39, 2012.
[16]	Romanelli M, Macchia M, Panduri S et al. Clinical evaluation of the efficacy and safety of a medical device in various forms containing Triticum vulgare for the treatment of venous leg ulcers. A randomized pilot study. Drug Design Development and Therapy, 2015. submitted for publication
[17]	Trombetta D, et al., Effect of polysaccharides from Opuntia ficus indica (L.) cladodes on the healing of dermal wounds in the rat. Phytomed, 13:352-358, 2006
[18]	Saija A, et al., In vitro evaluation of the antioxidant activity and biomembrane interaction of the plant phenols oleuropein and hydroxytyrosol. Int J Pharmaceutics, 166:123-133, 1998
[19]	De Leonardis A, et al., Isolation of a hydroxyltyrosol-rich extract from olive leaves (Olea europeae L.) and evaluation of its antioxidant properties and bioactivity. Eur Food Res Technol, 226: 653-659, 2008.
[20]	Munoz Lopez Eliana E, Saponati G. Topical treatment of oral mucositis in cancer children with Triticum vulgare extract. A case series. Int J Med Pharm Case Reports, 2015; 2 (2): 48-52.